Sonja W. Scholz
Sonja W. Scholz | |
|---|---|
 | |
| Alma mater | Medical University of Innsbruck University College London |
| Scientific career | |
| Fields | Neurology, neurogenetics |
| Institutions | National Institutes of Health |
Sonja W. Scholz is a neurologist and neurogeneticist who is a senior investigator in the neurodegenerative diseases research unit at the National Institute of Neurological Disorders and Stroke.
Life
[edit]Scholz received a medical degree from the Medical University of Innsbruck.[1] Following graduation, she was a post-doctoral fellow at the laboratory of neurogenetics at National Institute on Aging under the supervision of Andrew Singleton and John Hardy from 2005 to 2009.[2] From 2009 to 2001, she completed a postdoctoral fellowship in neuroscience at Georgetown University.[3] She obtained a Ph.D. in neurogenomics from the University College London in 2010.[1][2] She completed an internship and adult neurology residency at Johns Hopkins Hospital from 2011 to 2015.[2][3]
Scholz is a neurologist and neurogeneticist specialized in movement and cognitive disorders.[2] In 2015, Scholz received the McFarland Transition to Independence Award for neurologist-scientists, joining the National Institute of Neurological Disorders and Stroke (NINDS) as an assistant clinical investigator.[2][1] In 2018, she became a Lasker Clinical Research Tenure Track Investigator within the NINDS Neurogenetics Branch.[2][3] In 2024, she was tenured as a senior investigator in the neurodegenerative diseases research unit.[3]
Her laboratory focuses on identifying genetic causes of neurodegenerative diseases, such as dementia with Lewy bodies, multiple system atrophy, and frontotemporal dementia.[2] Her work in neurogenetics has contributed to a better understanding of diseases such as Alzheimer's disease and Parkinson's disease.[3] In her laboratory, genomic techniques are used to study additional neurodegenerative disorders, including Lewy body dementia, multiple system atrophy, frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.[3] The focus of her research is on identifying the molecular genetic mechanisms underlying these diseases to inform potential therapeutic approaches.[3] Scholz's research is conducted in collaboration with national and international partners, utilizing resources from the NIH Intramural Research Program.[3] Future directions of her work include integrating molecular data into diagnostic and therapeutic strategies for neurodegenerative diseases.[3] Her team aims to generate large-scale genomic and multi-omic datasets from clinically characterized patients, sharing these data to support collaboration within the neuroscience community and advance the development of treatments for complex neurodegenerative conditions.[3]
References
[edit]- ^ a b c "Sonja Scholz". The Lancet Neurology. 16 (12): 961. December 2017. doi:10.1016/S1474-4422(17)30342-3. PMID 29165256.
- ^ a b c d e f g "Sonja W. Scholz, M.D., Ph.D. | Principal Investigators | NIH Intramural Research Program". irp.nih.gov. Retrieved 2024-10-13.
This article incorporates text from this source, which is in the public domain.
- ^ a b c d e f g h i j "Colleagues: Recently Tenured | NIH Intramural Research Program". irp.nih.gov. Retrieved 2024-10-13. This article incorporates text from this source, which is in the public domain.
This article incorporates public domain material from websites or documents of the National Institutes of Health.
- Living people
- Medical University of Innsbruck alumni
- Alumni of University College London
- Austrian neurologists
- Austrian geneticists
- Women geneticists
- Women neurologists
- 21st-century Austrian women physicians
- 21st-century Austrian biologists
- Austrian women biologists
- Physician-scientists
- Women medical researchers
- Austrian medical researchers
- Austrian emigrants to the United States
- National Institutes of Health people